Leibniz-institut Fuer Naturstoff-forschung Und Infektionsbiologie E.v. Hans-knoell-institut

Leibniz-Institut Für Naturstoff-Forschung Und Infektionsbiologie—hans-Knöll-Institut

Leibniz-institut Fuer Naturstoff-forschung Und Infektionsbiologie

Leibniz-Institut Für Naturstoff-Forschung Und Infektionsbiologie

Martin Roth

Ute Moellmann

Hans-Martin Dahse

Christian Hertweck

Florian Kloss

Emerson Zang

Miguel Tovar

Susanna Graefe, Legal Representative

Thorger Lincke

Kerstin Herold

Ingrid Groth

Friedrich Gollmick

Keishi Ishida

Karin Brigitte Charlotte Graefe, Legal Representative

Lisa Mahler

Swantje Behnken

Andrea Graefe, Legal Representative

A system for incubating microfluidic droplets includes a droplet incubator, a gas exchanger and a conveyor. A method provides homogeneous incubation conditions in a droplet incubator by targeted introduction of gases and/or gas mixtures into a carrier fluid.

System for incubating microfluidic droplets and method for producing homogeneous incubation conditions in a droplet incubation unit

This invention relates to the field of biologically active compounds and specifically to closthioamides, pharmaceutical compositions comprising these compounds, and their use as antibiotic, antifungal, and/or cytotoxic agent.

Closthioamides, compositions, and methods for treating bacterial or fungal infections or cancer

The invention relates to the novel antibiotic HKI10311129 which has a molecular weight of 1113 and the summation formula CHNO. The invention also relates to a method for producing said antibiotic using the microorganismspec. DSM 13059, and to the use thereof as an antibacterial substance which is especially effective against infections with Gram positive bacteria, especially antibiotic-resistant germs.

HKI10311129, novel antibiotic, method for producing the same and the use thereof

Growing community of inventors

Jena, Germany

Martin Roth